Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 2
2013 1
2014 4
2015 3
2016 1
2017 1
2021 5
2022 4
2023 6
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Action on sickle cell retinopathy: the time is now.
Dinah C, Greystoke B, Mueller I, Talks J. Dinah C, et al. Eye (Lond). 2022 Jun;36(6):1138-1139. doi: 10.1038/s41433-021-01918-y. Epub 2022 Jan 28. Eye (Lond). 2022. PMID: 35087214 Free PMC article. No abstract available.
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.
Jackson TL, Desai R, Wafa HA, Wang Y, Peacock J, Peto T, Chakravarthy U, Dakin H, Wordsworth S, Lewis C, Clinch P, Ramazzotto L, Neffendorf JE, Lee CN, O'Sullivan JM, Reeves BC; STAR study group. Jackson TL, et al. Lancet. 2024 Jul 6;404(10447):44-54. doi: 10.1016/S0140-6736(24)00687-1. Epub 2024 Jun 11. Lancet. 2024. PMID: 38876132 Free article. Clinical Trial.
What is Occluding Our Understanding of Retinal Vein Occlusion?
Dinah C, Chang A, Lee J, Li WW, Singh R, Wu L, Wong D, Saffar I. Dinah C, et al. Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10. Ophthalmol Ther. 2024. PMID: 39387960 Free PMC article. No abstract available.
Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial.
Maguire MJ, Laidlaw A, Hammond C, Muqit MMK, Steel D, Dinah C, Lee E, Hillier R, Almeida G, Hussain R, Gordon-Bennet P, Hughes E, Alexander P, Vaideanu-Collins D, Jackson T. Maguire MJ, et al. Among authors: dinah c. JAMA Ophthalmol. 2024 Sep 1;142(9):837-844. doi: 10.1001/jamaophthalmol.2024.2777. JAMA Ophthalmol. 2024. PMID: 39115867 Clinical Trial.
Antibiotic name correction.
Dinah C, Sallam A, Towler H. Dinah C, et al. Ophthalmology. 2007 Sep;114(9):1788. doi: 10.1016/j.ophtha.2007.05.061. Ophthalmology. 2007. PMID: 17822982 No abstract available.
Towards a Therapy for Geographic Atrophy: A Patient's Experience.
Enoch J, Ghulakhszian A, Sekhon M, Crabb DP, Taylor DJ, Dinah C. Enoch J, et al. Among authors: dinah c. Patient Prefer Adherence. 2023 Feb 1;17:299-310. doi: 10.2147/PPA.S386662. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 36756537 Free PMC article.
33 results